# LACTYFERRIN™ Forte and ZINC Defense™ and Standard of Care (SOC) vs SOC in the Treatment of Non-hospitalized Patients With COVID-19

> **NCT05783180** · PHASE2 · WITHDRAWN · sponsor: **Jose David Suarez, MD**

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Sesderma LACTYFERRIN™ Forte and Sesderma ZINC Defense™
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05783180
- **Lead sponsor:** Jose David Suarez, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-06
- **Primary completion:** 2023-06
- **Final completion:** 2024-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor decided not to move forward with the trial
- **Last updated:** 2023-11-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05783180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05783180, "LACTYFERRIN™ Forte and ZINC Defense™ and Standard of Care (SOC) vs SOC in the Treatment of Non-hospitalized Patients With COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05783180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*